Modulation of growth factor action: implications for the treatment of cardiovascular diseases.
about
Src family kinases negatively regulate platelet-derived growth factor alpha receptor-dependent signaling and disease progressionInhibition of vascular smooth muscle cell proliferation by Gentiana lutea root extractsNuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells.Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival.Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitorsA novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinasesCardiovascular protective effects of 17beta-estradiol metabolites.Fibroblast growth factors in myocardial ischemia / reperfusion injury and ischemic preconditioning.Treatment of hepatic fibrosis: almost there.Protective effects of non-mitogenic human acidic fibroblast growth factor on hydrogen peroxide-induced damage to cardiomyocytes in vitroThe prevention of diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth factor is probably mediated by the suppression of oxidative stress and damagePreclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents.HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas.Targeting angiogenesis to restore the microcirculation after reperfused MI.Coronary vessel development and insight towards neovascular therapy.Antiangiogenic treatments and mechanisms of action in renal cell carcinoma.Complete structure of an increasing capillary permeability protein (ICPP) purified from Vipera lebetina venom. ICPP is angiogenic via vascular endothelial growth factor receptor signalling.Trafermin for stroke recovery: is it time for another randomized clinical trial?Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report.Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial.Long-term effects for acute phase myocardial infarct VEGF165 gene transfer cardiac extracellular matrix remodeling.Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis.Serum starvation and growth factor receptor expression in vascular smooth muscle cells.Margatoxin inhibits VEGF-induced hyperpolarization, proliferation and nitric oxide production of human endothelial cells.Glucose lowers the threshold for human aortic vascular smooth muscle cell migration: inhibition by protein phosphatase-2A.PDGF-BB induces vascular smooth muscle cell expression of high molecular weight FGF-2, which accumulates in the nucleus.Chronic refractory angina pectoris: recent progress and remaining challenges.
P2860
Q22253382-89E66D5E-C641-430F-B579-E665D7E44EF7Q28486286-B7FF0C11-55BC-400E-A479-9EFB0E88DB17Q30307673-45C19A69-BF90-4BC4-BC79-5659333C4658Q33305429-13214E0B-D147-46C6-B68E-9376A2A79264Q33698419-ECED3688-4CFE-43DB-B63D-A483145DC490Q33890319-62DCE947-0A49-41B7-974D-735854063ACCQ34377353-DB7D2E37-9C2D-40CA-851D-E9E7AB1B380EQ34687823-4716C8F7-C26C-4EC3-958D-E8F211FC86BFQ35046541-123C4C46-8794-41ED-A474-A92BDD64E174Q35059612-3003DE9D-24ED-4E96-A717-A70754341260Q35070159-8784639F-8C8F-42E4-B7AD-8BB918BC7091Q35755466-9C160232-F3F7-4033-9233-04D3101F136CQ37266075-D7C0F132-0BBD-483D-9AFB-C7FDFF22ECFDQ37520596-8B7EB84A-050F-4389-87E1-EB1009489485Q37534988-C8658976-4A78-468D-A294-D6DAA25F413EQ37875792-BD3D2CC4-F0E1-4C2A-B5C1-4A21873C6212Q40731223-25F599BF-0A81-496A-90F6-E7D70B872BE7Q42614796-F48A9B02-C219-47BE-B268-9B29EEEFCE08Q42940641-8EDB657B-32DA-4252-98CC-CA1C9420DB07Q43619839-E5D1F571-DB6F-42DD-80CE-50BFC7A511FAQ43846955-FA3522C8-843F-4296-91E7-D3F96D0C83C6Q45105336-C801E3A2-6C8B-4A0E-B2E0-1AF91BCF8FC2Q45855018-F4DD2D30-503A-4E52-9CEA-2B804A1B8541Q46618898-36CEE665-201E-478B-8CCB-CAE5CAE75A68Q46702352-4DCFE174-6B66-4D06-A039-324D6AA55418Q47378034-A93C6F5B-0E49-4533-8541-321BE5294230Q50116057-BF0F2395-BD1D-4D28-87FC-D02B31F1BEF7
P2860
Modulation of growth factor action: implications for the treatment of cardiovascular diseases.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Modulation of growth factor ac ...... nt of cardiovascular diseases.
@en
type
label
Modulation of growth factor ac ...... nt of cardiovascular diseases.
@en
prefLabel
Modulation of growth factor ac ...... nt of cardiovascular diseases.
@en
P1433
P1476
Modulation of growth factor ac ...... nt of cardiovascular diseases.
@en
P2093
Waltenberger J
P304
P356
10.1161/01.CIR.96.11.4083
P407
P577
1997-12-01T00:00:00Z